 |
PDBsum entry 2k8m
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Protein transport
|
PDB id
|
|
|
|
2k8m
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Biochem Biophys Res Commun
380:514-519
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
S100A13-C2A binary complex structure-a key component in the acidic fibroblast growth factor for the non-classical pathway.
|
|
S.K.Mohan,
S.G.Rani,
S.M.Kumar,
C.Yu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Fibroblast growth factors (FGFs) are key regulators of cell proliferation,
differentiation, tumor-induced angiogenesis and migration. FGFs are essential
for early embryonic development, organ formation and angiogenesis. They play
important roles in tumor formation, inflammation, wound healing and restenosis.
The biological effects of FGFs are mediated through the activation of the four
transmembrane phosphotyrosine kinase receptors (FGFRs) in the presence of
heparin sulfate proteoglycans (HSPGs) and therefore require the release of FGFs
into the extracellular space. However, FGF-1 lacks the signal peptide required
for the releasing of these proteins through the classical endoplasmic reticulum
(ER)-Golgi secretary pathway. Maciag et al. demonstrated that FGF-1 is exported
through a non-classical release pathway involving the formation of a specific
multiprotein complex [M. Landriscina, R. Soldi, C. Bagala, I. Micucci, S.
Bellum, F. Tarantini, I. Prudovsky, T. Maciag, S100A13 participates in the
release of fibroblast growth factor 1 in response to heat shock in vitro, J.
Biol. Chem. 276 (2001) 22544-22552; C.M. Carreira, T.M. LaVallee, F. Tarantini,
A. Jackson, J.T. Lathrop, B. Hampton, W.H. Burgess, T. Maciag, S100A13 is
involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1
release in vitro, J. Biol. Chem. 273 (1998) 22224-22231; T.M. LaValle, F.
Tarantini, S. Gamble, C.M. Carreira, A. Jackson, T. Maciag, Synaptotagmin-1 is
required for fibroblast growth factor-1 release, J. Biol. Chem. 273 (1998)
22217-22223; C. Bagalá, V. Kolev, A. Mandinova, R. Soldi, C. Mouta, I.
Graziani, I, Prudovsky, T. Maciag, The alternative translation of synaptotagmin
1 mediates the non-classical release of FGF1, Biochem. Biophys. Res. Commun. 310
(2003) 1041-1047]. The protein constituents of this complex include FGF-1,
S100A13 (a Ca(2+)-binding protein), and the p40 form of synaptotagmin 1 (Syt1).
To understand the molecular events in the FGF-1 releasing pathway, we have
studied the interactions of S100A13 with C2A by (1)H-(15)N HSQC titration and
3D-filtered NOESY experiments. We characterized the binary complex structure of
S100A13-C2A by using a variety of multi-dimensional NMR experiments. This
complex acts as a template for FGF-1 dimerization and multiprotein complex
formation.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|